Law Offices of Howard G. Smith reminds investors of the upcoming August 17, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Embecta Corp. ("Embecta ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Embecta Corp. (NASDAQ:EMBC) and certain of the Company's senior executives for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...
As of April 2, 2025, the average one-year price target for Embecta is $21.47/share. The forecasts range from a low of $18.38 to a high of $27.30. The average price target represents an increase of ...
Embecta Corp. (NASDAQ:EMBC) posted on Friday the second-quarter 2025 adjusted earnings of 70 cents per share, up from 67 cents a year ago, beating the consensus of 53 cents. The diabetes care company ...
As of November 21, 2024, the average one-year price target for Embecta is $16.39/share. The forecasts range from a low of $13.13 to a high of $19.11. The average price target represents a decrease of ...
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...
In a report released today, Marie Thibault from BTIG maintained a Hold rating on Embecta Corporation (EMBC – Research Report). The company’s shares opened today at $16.02. According to TipRanks, ...
Embecta Corp. (EMBC Quick Quote EMBC - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, EMBC broke through the 200-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results